SpringWorks Therapeutics, Inc. (SWTX)

NASDAQ: SWTX · IEX Real-Time Price · USD

37.72

+1.26 (3.46%)

At close: Jul 19, 2024, 4:00 PM

38.72

+1.00 (2.65%)

Pre-market: Jul 22, 2024, 8:41 AM EDT

SpringWorks Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-339.07	-325.1	-277.42	-173.91	-45.57	-50.58	Upgrade
Depreciation & Amortization	3.91	3.32	1.9	1.48	1.4	0.19	Upgrade
Share-Based Compensation	101.6	94.53	72.97	38.44	10.03	3.11	Upgrade
Other Operating Activities	-6.35	4.46	40.99	6.11	1.95	7.56	Upgrade
Operating Cash Flow	-239.91	-222.8	-161.56	-127.88	-32.19	-47.44	Upgrade
Capital Expenditures	-4.99	-7.39	-10.2	-2.02	-0.64	-0.67	Upgrade
Acquisitions	-11.04	-2.8	-4.2	0	-3.5	-3.59	Upgrade
Change in Investments	-26.37	44.94	-201.2	85.61	-414.69	0	Upgrade
Investing Cash Flow	-42.39	34.75	-215.6	83.59	-418.83	-4.26	Upgrade
Share Issuance / Repurchase	297.94	296.64	340.7	1.16	270.49	169.75	Upgrade
Other Financing Activities	-	-	-	-	-	163.96	Upgrade
Financing Cash Flow	297.94	296.64	340.7	1.16	270.49	333.71	Upgrade
Net Cash Flow	15.64	108.6	-36.46	-43.13	-180.54	282	Upgrade
Free Cash Flow	-244.89	-230.18	-171.76	-129.89	-32.83	-48.11	Upgrade
Free Cash Flow Margin	-925.76%	-4225.81%	-	-	-93.81%	-	Upgrade
Free Cash Flow Per Share	-3.32	-3.65	-3.22	-2.68	-0.76	-3.62	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).